Dynamics Rationalize Proteolytic Susceptibility of the Major Birch Pollen Allergen Bet v 1. 2020

Anna S Kamenik, and Florian Hofer, and Philip H Handle, and Klaus R Liedl
Center for Molecular Biosciences Innsbruck, Institute of General, Inorganic and Theoretical Chemistry, University of Innsbruck, Innsbruck, Austria.

Proteolytic susceptibility during endolysosomal degradation is decisive for allergic sensitization. In the major birch pollen allergen Bet v 1 most protease cleavage sites are located within its secondary structure elements, which are inherently inaccessible to proteases. The allergen thus must unfold locally, exposing the cleavage sites to become susceptible to proteolysis. Hence, allergen cleavage rates are presumed to be linked to their fold stability, i.e., unfolding probability. Yet, these locally unfolded structures have neither been captured in experiment nor simulation due to limitations in resolution and sampling time, respectively. Here, we perform classic and enhanced molecular dynamics (MD) simulations to quantify fold dynamics on extended timescales of Bet v 1a and two variants with higher and lower cleavage rates. Already at the nanosecond-timescale we observe a significantly higher flexibility for the destabilized variant compared to Bet v 1a and the proteolytically stabilized mutant. Estimating the thermodynamics and kinetics of local unfolding around an initial cleavage site, we find that the Bet v 1 variant with the highest cleavage rate also shows the highest probability for local unfolding. For the stabilized mutant on the other hand we only find minimal unfolding probability. These results strengthen the link between the conformational dynamics of allergen proteins and their stability during endolysosomal degradation. The presented approach further allows atomistic insights in the conformational ensemble of allergen proteins and provides probability estimates below experimental detection limits.

UI MeSH Term Description Entries

Related Publications

Anna S Kamenik, and Florian Hofer, and Philip H Handle, and Klaus R Liedl
January 1996, Planta,
Anna S Kamenik, and Florian Hofer, and Philip H Handle, and Klaus R Liedl
July 2023, Biomolecules,
Anna S Kamenik, and Florian Hofer, and Philip H Handle, and Klaus R Liedl
January 2015, PloS one,
Anna S Kamenik, and Florian Hofer, and Philip H Handle, and Klaus R Liedl
February 1997, Protein expression and purification,
Anna S Kamenik, and Florian Hofer, and Philip H Handle, and Klaus R Liedl
March 2007, Biochemistry,
Anna S Kamenik, and Florian Hofer, and Philip H Handle, and Klaus R Liedl
February 2014, The Biochemical journal,
Anna S Kamenik, and Florian Hofer, and Philip H Handle, and Klaus R Liedl
January 2004, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology,
Anna S Kamenik, and Florian Hofer, and Philip H Handle, and Klaus R Liedl
September 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology,
Anna S Kamenik, and Florian Hofer, and Philip H Handle, and Klaus R Liedl
January 2021, Frontiers in immunology,
Anna S Kamenik, and Florian Hofer, and Philip H Handle, and Klaus R Liedl
January 1997, International archives of allergy and immunology,
Copied contents to your clipboard!